Nicox
is a France-based ophthalmology company that discovers, and develops novel ophthalmic therapeutics for the treatment of eye diseases... Read moreNicox
is a France-based ophthalmology company that discovers, and develops novel ophthalmic therapeutics for the treatment of eye diseases... Read more
News
Mar 19, 2025
Benzinga
Nicox: Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial
Mar 06, 2025
FinanzNachrichten
Nicox: NICOX SA: Nicox Extends Cash Runway into Q4 2025
Mar 03, 2025
Benzinga
Nicox: Nicox Presents New Analysis from the NCX 470 Mont Blanc Trial and Provides Development Update
Jan 28, 2025
Benzinga
Nicox: Nicox Announces Scientific Presentation and Conference Attendance in H1 2025
Jan 21, 2025
FinanzNachrichten
Nicox: NICOX SA: Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights
Dec 04, 2024
Yahoo
Nicox: Nicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream
Dec 02, 2024
FinanzNachrichten
Nicox: NICOX SA: Nicox's Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected
Oct 17, 2024
FinanzNachrichten
Nicox: NICOX SA: Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results
Oct 14, 2024
FinanzNachrichten
Nicox: NICOX SA: Nicox and Soleus Sign $16.5 million Royalty and Equity Financing
Sep 24, 2024
Pharmabiz
Nicox: Nicox, and Glaukos ink exclusive NCX 1728 research and global licensing option agreement
Nicox Competitors
1
2
3
4
5
6
7
8
9
10